{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:02:42Z","timestamp":1792443762211,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.aohep.2023.101154","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T13:01:38Z","timestamp":1695387698000},"page":"101154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018"],"prefix":"10.1016","volume":"29","author":[{"given":"Tongtong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaswamy","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Crutchlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.aohep.2023.101154_bib0001","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.aohep.2023.101154_bib0002","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0004","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.28677","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort","volume":"64","author":"Setiawan","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","author":"Younossi","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0008","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ajg.2014.155","article-title":"Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis","volume":"109","author":"Meffert","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0009","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2023.101154_bib0010","article-title":"External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan","volume":"10","author":"Yang","year":"2015","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107584","article-title":"Non-laboratory-based self-assessment screening score for non-alcoholic Fatty liver disease: development, validation and comparison with other scores","volume":"9","author":"Lee","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.aohep.2023.101154_bib0012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-14-0112","article-title":"External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals","volume":"171","author":"Cuthbertson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.aohep.2023.101154_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.aohep.2023.101154_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.aohep.2023.101154_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12072-018-09926-z","article-title":"Race\/ethnicity\u2011based temporal changes in prevalence of NAFLD\u2011related advanced fibrosis in the United States, 2005\u20132016","author":"Kim","year":"2019","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.aohep.2023.101154_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population","volume":"3","author":"Arshad","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2023.101154_bib0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101154_bib0018","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0019","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0021","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0022","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0023","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2023.101154_bib0024","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u20132021 updateq","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2023.101154_bib0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","article-title":"Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity","volume":"43","author":"Musso","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.aohep.2023.101154_bib0026","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease: a critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2023.101154_bib0027","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nrgastro.2013.175","article-title":"Noninvasive evaluation of NAFLD","volume":"10","author":"Castera","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0028","doi-asserted-by":"crossref","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology;43:1317-25.","DOI":"10.1002\/hep.21178"},{"issue":"1","key":"10.1016\/j.aohep.2023.101154_bib0029","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101154_bib0030","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey. Access from: https:\/\/wwwcdcgov\/nchs\/nhanes\/indexhtm 2017."},{"issue":"7","key":"10.1016\/j.aohep.2023.101154_bib0031","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"2009","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2023.101154_bib0032","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.dsx.2018.11.026","article-title":"Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification","volume":"13","author":"Wang","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.aohep.2023.101154_bib0033","unstructured":"NHANES data documention C, and frequencies\u2013cardiovascular health (CDQ_H). https:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/2013-2014\/CDQ_H.htm."},{"issue":"21","key":"10.1016\/j.aohep.2023.101154_bib0034","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/jama.2019.15883","article-title":"Using the 9-Item patient health questionnaire to screen for and monitor depression","volume":"322","author":"Zimmerman","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.aohep.2023.101154_bib0035","doi-asserted-by":"crossref","first-page":"I1476","DOI":"10.1136\/bmj.l1476","article-title":"DEPRESsion screening data (DEPRESSD) collaboration. Accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis","volume":"365","author":"Levis","year":"2019","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0036","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0037","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aohep.2023.101154_bib0038","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. Specifying Weighting Parameters Access from: https:\/\/wwwcdcgov\/nchs\/tutorials\/nhanes\/SurveyDesign\/Weighting\/introhtm 2013."},{"issue":"1","key":"10.1016\/j.aohep.2023.101154_bib0039","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-019-0972-6","article-title":"Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States","volume":"19","author":"Golabi","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.aohep.2023.101154_bib0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: The third national health and nutrition examination survey, 1988\u20131994","volume":"178","author":"Lazo","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.aohep.2023.101154_bib0041","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5604\/01.3001.0010.8644","article-title":"More evidence for the genetic susceptibility of Mexican population to nonalcoholic fatty liver disease through PNPLA3","volume":"17","author":"Chinchilla-L\u00f3pez","year":"2018","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0042","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2013.02.011","article-title":"Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third national health and nutrition examination survey","volume":"11","author":"Hernaez","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"17","key":"10.1016\/j.aohep.2023.101154_bib0043","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3748\/wjg.v20.i17.4987","article-title":"NAFLD prevalence differs among hispanic subgroups: the multi-ethnic study of atherosclerosis","volume":"20","author":"Fleischman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101154_bib0044","doi-asserted-by":"crossref","first-page":"e0214","DOI":"10.1097\/MD.0000000000010214","article-title":"Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.aohep.2023.101154_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/MEG.0b013e32834b8d52","article-title":"Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase","volume":"23","author":"L\u00f3pez-Su\u00e1rez","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101154_bib0046","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/HJH.0000000000000532","article-title":"Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk","volume":"33","author":"Aneni","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.aohep.2023.101154_bib0047","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/HYPERTENSIONAHA.120.15220","article-title":"Nonalcoholic fatty liver disease and advanced fibrosis in US adults across blood pressure categories","volume":"76","author":"Ciardullo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.aohep.2023.101154_bib0048","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.aohep.2023.101154_bib0049","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/hepr.12647","article-title":"Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study","volume":"46","author":"Sun","year":"2016","journal-title":"Hepatol Res"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2023.101154_bib0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jcag\/gwz047.187","article-title":"A188 Comparing the performance of fibrosis-4 (FIB-4) and non-alcoholic fatty liver disease fibrosis score (NFS) with fibroscan scores in non-alcoholic fatty liver disease","volume":"3","author":"Cox","year":"2020","journal-title":"J Can Assoc Gastroenterol"},{"issue":"10","key":"10.1016\/j.aohep.2023.101154_bib0051","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2023.101154_bib0052","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc19-1071","article-title":"Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes","volume":"43","author":"Bril","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.aohep.2023.101154_bib0053","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/liv.13549","article-title":"Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease","volume":"38","author":"Joo","year":"2018","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.aohep.2023.101154_bib0054","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2023.101154_bib0055","doi-asserted-by":"crossref","first-page":"916","DOI":"10.14309\/ajg.0000000000000153","article-title":"Impact of obesity and alanine aminotransferase levels on the diagnostic accuracy for advanced liver fibrosis of noninvasive tools in patients with nonalcoholic fatty liver disease","volume":"114","author":"Petta","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.aohep.2023.101154_bib0056","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes","year":"2022","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.aohep.2023.101154_bib0057","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","article-title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","volume":"8","author":"M\u00f3zes","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.aohep.2023.101154_bib0058","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep4.1935","article-title":"Predicting NAFLD prevalence in the United States using national health and nutrition examination survey 2017-2018 transient elastography data and application of machine learning","volume":"6","author":"Noureddin","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:46:55Z","timestamp":1761648415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1665268123002570"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101154","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and The Author(s). Published by Elsevier Espa\u00f1a S.L.U. on behalf of Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C.","name":"copyright","label":"Copyright"}],"article-number":"101154"}}